Is this actionable now?

unknown. Topic-specific requests for proposals and review cycles rather than a universal rolling grant.

A research or company team must answer a live Diagnostics Accelerator RFP and propose an accessible biomarker or diagnostic with a credible validation and translation plan.

What burden and restrictions apply?

Scientific milestones, financial reporting, data and publication obligations depend on whether support is a grant or mission-related investment. Restricted to the approved biomarker or diagnostic development plan.

What evidence exists?

The Diagnostics Accelerator is a dedicated global funding platform for accessible Alzheimer's and dementia biomarkers. No comparable current application denominator, award count and acceptance rate are published.

Diagnostics Accelerator

Proposal-specific research grant or mission-related investment for Alzheimer's and related-dementia diagnostics; current mechanism and ceiling vary by RFP · Alzheimer's Drug Discovery Foundation

Diagnostics Accelerator is a grant programme from Alzheimer's Drug Discovery Foundation for Academic groups and biotechnology companies worldwide developing accessible biomarkers and diagnostics for Alzheimer's disease and related dementias Current lifecycle: unknown. Real economics: Proposal-specific research grant or mission-related investment for Alzheimer's and related-dementia diagnostics; current mechanism and ceiling vary by RFP.

Tier 3foundationglobalhealthalzheimers

Apply Official site Open in the live directory

Key facts

Funder	Alzheimer's Drug Discovery Foundation
Amount	Proposal-specific research grant or mission-related investment for Alzheimer's and related-dementia diagnostics; current mechanism and ceiling vary by RFP
Decision time	No universal application-to-decision interval is published for the currently verified route.
Eligibility	A research or company team must answer a live Diagnostics Accelerator RFP and propose an accessible biomarker or diagnostic with a credible validation and translation plan.
Restrictions	Scientific milestones, financial reporting, data and publication obligations depend on whether support is a grant or mission-related investment. Restricted to the approved biomarker or diagnostic development plan.
Status	closed

Always confirm on the official page before applying — dates and terms change.

Application process

Select a live diagnostics RFP
Submit letter of intent where required
Receive invitation for a full proposal
Complete scientific and commercial diligence
Execute grant or investment terms

Background

Alzheimer's Drug Discovery Foundation operates Diagnostics Accelerator. This pass separates direct cash, repayable finance, credits, incentives and umbrella programs so later ranking does not compare unlike instruments. The Diagnostics Accelerator is a dedicated global funding platform for accessible Alzheimer's and dementia biomarkers.

How the application really works

Select a live diagnostics RFP → Submit letter of intent where required → Receive invitation for a full proposal → Complete scientific and commercial diligence → Execute grant or investment terms

Tips

Show direct fit with Alzheimer's disease.
Show direct fit with dementia diagnostics.
Show direct fit with biomarkers.

Watch out for

Current lifecycle is unknown.
Scientific milestones, financial reporting, data and publication obligations depend on whether support is a grant or mission-related investment.
Restricted to the approved biomarker or diagnostic development plan.

Track record

The Diagnostics Accelerator is a dedicated global funding platform for accessible Alzheimer's and dementia biomarkers.

No comparable current application denominator, award count and acceptance rate are published.

Frequently asked questions

Is this actionable now?: unknown. Topic-specific requests for proposals and review cycles rather than a universal rolling grant.
What is the real economic value?: Proposal-specific research grant or mission-related investment for Alzheimer's and related-dementia diagnostics; current mechanism and ceiling vary by RFP
Who is eligible?: A research or company team must answer a live Diagnostics Accelerator RFP and propose an accessible biomarker or diagnostic with a credible validation and translation plan.
How does selection work?: Select a live diagnostics RFP; Submit letter of intent where required; Receive invitation for a full proposal; Complete scientific and commercial diligence; Execute grant or investment terms. No universal application-to-decision interval is published for the currently verified route.
What burden and restrictions apply?: Scientific milestones, financial reporting, data and publication obligations depend on whether support is a grant or mission-related investment. Restricted to the approved biomarker or diagnostic development plan.
What evidence exists?: The Diagnostics Accelerator is a dedicated global funding platform for accessible Alzheimer's and dementia biomarkers. No comparable current application denominator, award count and acceptance rate are published.

Sources

www.alzdiscovery.org/research-and-grants/funding-opportunities/diagnostics-accelerator — Official scientific scope, applicants and current RFP route (checked 2026-08-10)
www.alzdiscovery.org/research-and-grants/funding-opportunities — Official source used for the 2026-08-11 verification correction. (checked 2026-08-11)